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Traditional Chinese medicine (TCM) which functions as chemotherapeutic or adjuvantly chemotherapeutic agents
has been drawing a great many eyeballs for its easy obtain and significant antitumor effects accompanied with less
toxic and side effects. PDT (photodynamic therapy) utilizes the fact that certain compounds coined as photosensitizers,
when exposed to light of a specific wavelength, are capable of generating cytotoxic reactive oxygen species (ROS)
such as hydroxyl radical, hydrogen peroxide, and superoxide to kill cancer cells. Combinations of cancer therapeutic
modalities are studied to improve the efficacy of treatment. This study aimed to explore a new strategy of coupling
of titanium dioxide whiskers (TiO2 Ws) with the anticancer drug gambogic acid (GA) in photodynamic therapy. The
nanocomposites were coined as GA-TiO2. The combination of TiO2 Ws with GA induced a remarkable enhancement
in antitumor activity estimated by MTT assay, nuclear DAPI staining, and flow cytometry. Furthermore, the possible
signaling pathway was explored by reverse transcription polymerase chain reaction (RT-PCR) and Western blot
assay. These results identify TiO2 Ws of good biocompatibility and photocatalytic activity. In human leukemia
cells (K562 cells), TiO2 Ws could obviously increase the intracellular concentration of GA and enhance its
potential antitumor efficiency, suggesting that TiO2 Ws could act as an efficient drug delivery carrier targeting
GA to carcinoma cells. Moreover, photodynamic GA-TiO2 nanocomposites could induce an evident
reinforcement in antitumor activity with UV illumination. These results reveal that such modality combinations
put forward a promising proposal in cancer therapy.
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Chemotherapy plays a fundamental role in the treatment
for the most majority of cancers, including leukemia. It
has been well documented that traditional Chinese
medicine (TCM), as a crucial constituent member of
complementary and alternative medicine, has been
widely used in the preventive and therapeutic treatment
for a variety of cancers during the last decades [1-3].
Gambogic acid (GA, C38H44O8), isolated from gamboge
resin obtained from the Garcinia hanburyi tree [4-6], is
one of such recently discovered TCM. Whereas evident
antitumor properties has been addressed to date in a
plethora of carcinoma cell lines, the present clinical
application of GA is plagued by its serious side effects,* Correspondence: xu_peipei0618@163.com; ouyangj211@163.com
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in any medium, provided the original work is psuch as phlebophlogosis, myelosuppression, and oral
ulcers [7].
To maximize antitumor effects and lower undesirable
side effects of GA associated with high dosages of che-
motherapeutic agents, new therapies in cancer treatment
applying nanoparticle-based drug delivery systems are
being developed and have recently drawn substantial ex-
perimental interest.
Titanium dioxide whiskers (TiO2 Ws), which are com-
monly used in many biomedical studies including pro-
moting tissue repair, drug delivery, cell separation, tissue
targeting, transfection, and cellular/molecular tracking,
have been well elucidated till now that they are not just
proved to be environmental friendly but also possess ex-
clusive photocatalytic activity, which can generate react-
ive oxygen species (ROS) upon UV irradiation [8-12].
These properties tend to allow TiO2 Ws to be used in
photodynamic therapy (PDT), which highly potentiatespen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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elicits ROS formation, leading to cellular destruction
eventually [13].
Based on these observations, we developed new GA-
TiO2 nanocomposites to facilitate the properties of GA,
in which TiO2 Ws were initially coated with GA. In this
study, we estimated the cytotoxicity and efficiency in
PDT, examined the effectiveness of antitumor activity in
K562 cells, and investigated the antitumor mechanism of
the nanocomposites, suggesting that TiO2 Ws could not
only be applied as the drug delivery system to carry GA
into cancer cells but could also improve the antitumor
effects for synergistic PDT.
Methods
Materials
GA (molecular formula, C38H44O8; Kanion Pharmaceut-
ical Co. Ltd, Jiangsu, People’s Republic of China) was dis-
solved in dimethyl sulfoxide (DMSO; Sigma-Aldrich, St
Louis, MO, USA), stored at −20°C, and then suspended as
needed in Roswell Park Memorial Institute medium
(RPMI) (1640, Life Technologies, Carlsbad, CA, USA). The
cytotoxicity assay kit was obtained from were obtained
from Sigma-Aldrich (St Louis, MO, USA) and stored in
the dark. RT-PCR kit was from Takara Biotechnology
(Dalian, China). Horseradish peroxidase-conjugated IgG
antibodies, caspase-3, CDK2, CDK4, cyclin D1, p21 and
p27, and β-actin monoclonal antibodies were purchased
from Nanjing KeyGen Biotech Co., Ltd. (Nanjing, People’s
Republic of China). All the other regents used in this re-
port were analytical pure.
Preparation and characterization of TiO2 Ws
TiO2 Ws were prepared as described previously [14,15].
TiO2 Ws were finally obtained with the tetragonal crys-
tal structure (anatase). To characterize the microstruc-
ture of TiO2 Ws nanomaterial, the transmission electron
microscope (TEM) images were obtained using a JEM-
2100 transmission electron microscope (JEOL, Tokyo,
Japan) at room temperature (20°C ± 2°C). The sample
morphology was evaluated by scanning electron micros-
copy (SEM, JEOL JSM-5900). The crystalline phase was
determined by powder X-ray diffraction (XRD) pattern
(Bruker D8, Cu-Ka radiation) obtained on a DMAX-B
(Rigaku Denki Corp, Tokyo, Japan). N2 adsorption-
desorption measurements were employed to study the
textural properties at liquid nitrogen temperature (TriS-
tar II 3020, Norcross, GA, USA).
Cytotoxicity evaluation
Every experiment was repeated at least three times.
Ultrasonic treatments of TiO2 Ws for about 30 to
50 min were performed in the following experiments.
K562 and HELF cells in log phase were trypsinized andseeded in 96-well plates. After 24 h of incubation, the
cultured cells were rinsed in Dulbecco’s Modified Eagle’s
medium and incubated with different concentrations of
TiO2 Ws (1.56, 3.13, 6.25, 12.5, and 25 ug · mL
−1) for 6 h
at 37°C in the dark. Upon application of UV irradiation
(λ = 254 nm), in which the average intensity was
0.1 mW · cm−2 at the working plane, the effect of TiO2
Ws for K562 cell proliferation in the presence of UV ir-
radiation for 180 s was investigated. After treatment, the
cells were returned to the incubator for 24 h. The MTT
solutions were added into it, and the mixtures were in-
cubated for another 4 h. DMSO was added to solubilize
the formazan crystals, and OD 570 was recorded.
Preparation of GA-TiO2 nanocomposites and the
characterization of GA loading and release
GA solution was diluted by PBS (pH 7.4, 0.01 M) or
mixed into TiO2 Ws suspension (10 ug mL
−1) with vari-
ous concentration (0.125, 0.25, 0.5, 1, 2, 4 ug mL−1).
They were kept respectively below 4°C for more than
24 h in the dark to enable the GA to conjugate with
TiO2 Ws.
To allow the loading and estimation of the drug encap-
sulation efficiency, GA was separated from GA-TiO2
nanocomposites through centrifugation at 15,000 rpm for
30 min, and the supernatant was determined by HPLC.
Then, the loading efficiency (LE) and encapsulation effi-
ciency (EE) were calculated as the following equations:
loading efficiency
¼ ðamount of drug in drug‐loaded nanocomposites =
amount of drug‐loaded nanocompositesÞ 100%
encapsulation efficiency
¼ ðamount of drug in drug‐loaded nanocomposites =
initial amount of drugÞ 100%
The releasing capacity of GA from GA-TiO2 nano-
composites was investigated at pH 6.0 (pH of the envir-
onment around the tumor), and pH 7.4 (pH of
physiological blood). In brief, the GA-TiO2 nanocom-
posites were dispersed in PBS (pH 7.4, 5 mL) and trans-
ferred into the dialysis bag. The dialysis bag was
immersed in 95 mL PBS of pH 6.0 and 7.4, respectively.
Then, the release medium was continuously agitated
with stirring speed 100 rpm at 37°C. Two milliliters of
the external medium was collected and replaced with
the same fresh PBS at predetermined time intervals. The
amount of released GA in the medium was analyzed by
HPLC.
Cell culture
K562, human chronic myelogenous leukemia cells, were
obtained from the Institute of Hematology at the Chinese
Academy of Medical Sciences (Beijing, People’s Republic
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were obtained from the Shanghai Institute of Cells at the
Chinese Academy of Sciences (Shanghai, People’s Republic
of China). They were maintained in RPMI 1640 medium
supplemented with 10% heat-inactivated newborn bovine
serum (Sigma-Aldrich), 100 U/mL penicillin, and 100 mg/
mL streptomycin at 37°C in a humidified atmosphere with
5% CO2 and passaged once every 2 to 3 days.
In vitro cytotoxicity assays
K562 cells were seeded at 2 × 104 cells/well in a 96-well
plate and administered with different concentrations of
GA in solution (GA-Sol) or GA-TiO2 after 6 h. The
doses of GA incorporated in TiO2 share the same concen-
tration with GA-Sol. The culture medium was replaced
with 200 mL of three groups of medium containing free
GA (0, 0.125, 0.25, 0.5, 1, 2, and 4 μg/mL), GA-TiO2 nano-
composites, or GA-TiO2 nanocomposites with 180 s of
UV irradiation, at 6 h of cell culture. After irradiation, the
cell lines were returned to the incubator for 24 h. The
relative cytotoxicities of the three groups were assessed by
MTT assay. Microscope was employed for investigating
the morphological of cells.
DAPI staining
The cells were treated as the above three groups of
methods for 24 h and then were fixed with 4% polyoxy-
methylene prior to washing with PBS. The washed cells
were then stained with 1 mg/mL DAPI for 15 min in the
dark. The staining images were seen and observed under
the fluorescent microscope.
Flow cytometric apoptosis assay
FACSCalibur flow cytometry (Becton Dickinson, Franklin
Lakes, NJ, USA) was employed to test the apoptosis of
K562 cells which were treated in different systems. In
short, 4 × 105 K562 cells were washed after exposing to
GA, TiO2 Ws, GA-TiO2 composites, or GA-TiO2 compos-
ites (UV) for 24 h. Subsequently, 500 uL of binding buffer
was added and mixed with 5 udL of Annexin V-FITC; the
mixture was kept at room temperature for 15 min in the
dark. Flow cytometry analyses were performed using Cell-
Quest software to determine the apoptosis of cells, in
which the excitation wavelength was 488 nm and the emis-
sion wavelength was 530 nm, over 1 h.
Reverse transcription polymerase chain reaction (RT-PCR)
assay
The RT-PCR method was employed to determine the
transcription levels of genes at the transcription level.
The experimental procedures were carried out according
to the conventional methods. The designed PCR primers
were shown in Table 1.Western blot assay
The K562 cells were treated with the above methods for
24 h and then centrifuged at 10,000 rpm for 5 min. Western
blotting was done as a usual way. After normalization
with the corresponding expression of β-actin, the ex-
pression levels of apoptosis regulatory proteins (e.g.,
caspase-3, CDK2, CDK4, cyclin D1, p21, and p27) were
determined using densitometry scans.
Statistical analysis
All data were presented as mean ± standard deviation
(SD) of three identical experiments. Statistical signifi-
cance of the differences was determined using Student’s
t-test by means of SPSS software (version 13.0; SPSS Inc,
Chicago, IL, USA). P values <0.05 were considered as
statistically significant.
Results and discussion
Characterization of TiO2 Ws
The typical TEM images of the GA-TiO2 nanocompos-
ites are shown in Figure 1. The TiO2 nanostructures ex-
hibited a needle-like morphology, with an average size of
81.7 nm approximately in width and 200 to 1,000 nm in
length. These data indicate that TiO2 Ws have the uni-
form diameter distribution. The crystalline nature of the
as-prepared TiO2 was analyzed based on its X-ray dif-
fraction (XRD) pattern as displayed in Figure 2. The dif-
fraction peaks were quite consistent with those of bulk
TiO2, which could be indexed as TiO2 (JCPDF 35–0088).
Sharp peaks were observed, suggesting that the nanostruc-
tures possessed large crystalline domains and a high de-
gree of crystallinity. No other peaks related to impurities
were detected in the XRD patterns, confirming the purity
Figure 1 Characterization of TiO2 Ws. Notes: (A) SEM image (left) and (B) diameter distribution (right). (C) Typical TEM micrograph of a region
(left), and (D) high magnification of image (right).
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divided into four kinds of types including nanoparticles,
nanofibers, nanofilm, and nanobulk. TiO2 nanofibers
had better properties of photocatalysis, suggestive of
biomedical application in cancer therapy [16]. TiO2
Ws which we prepared is a kind of chopped nanofi-
ber with a high degree of monocrystalline. These find-
ings identify the former one as a better photocatalytic
agent.Figure 2 XRD patterns of TiO2 Ws (gray lines: anatase phase
JCPDS).Cytotoxicity testing and the application of TiO2 whiskers
in PDT
Cytotoxicity tests tend to be carried out prior to biomed-
ical application. The cytotoxicity of TiO2 Ws on K562 and
HELF (human embryonic lung fibroblast) cells was mea-
sured by MTT assay. About 95% of the cells survived after
treatment with TiO2 Ws at concentrations of up to
12.5 μg/mL, indicating low cytotoxicity (Figure 3). The
lack of cytotoxicity of TiO2 Ws suggests the potential ofFigure 3 The cytotoxicity of TiO2 Ws for K562 and HELF cells at
24 h in vitro. Notes: (a) The cytotoxicity of TiO2 Ws for K562 and
HELF cells (P > 0.05); (b) The cytotoxicity of TiO2 Ws (no UV) and
TiO2 Ws (with UV) for K562 cells (P < 0.05).
Xu et al. Nanoscale Research Letters  (2015) 10:94 Page 5 of 11applications in the fields of biomedical science and cancer
therapy. Accordingly, we chose 10.0 ug/mL TiO2 Ws for
subsequent studies.
Then, the photocatalytic activity of TiO2 Ws was esti-
mated on cancer cells. K562 cells which were treated with
the combination of TiO2 Ws and UV irradiation elicited a
remarkable enhancement of mortality compared with cells
only treated with TiO2 Ws, indicating the photocatalytic
activity of TiO2 Ws (Figure 3). We then observed that
treatment with TiO2 Ws resulted in an increase of lethality
on cancer cells in a dose-dependent manner.
PDT has emerged as an alternative and promising
noninvasive treatment for cancer [17]. PDT utilizes the
fact that certain compounds coined as photosensitizers,
when exposed to light of a specific wavelength, are cap-
able of generating cytotoxic ROS such as hydroxyl rad-
ical, hydrogen peroxide, and superoxide to kill cancer
cells [18,19]. TiO2, ZnO, and other semiconductor nano-
materials are regarded as the potential photosensitizing
agents among the photosensitizers for PDT, due to their
unique phototoxic effect upon the irradiation. They have
been used in the treatment of cutaneous squamous cell
and basal cell carcinomas as well as cancers of the head,
neck, lung, esophagus, and bladder [20]. Compared to
other photosensitizers, TiO2 Ws which we prepared are
bio-safe and non-cytotoxic, leading to priority applica-
tion in clinical chemotherapy. TiO2 Ws, therefore, can
be one of the promising nanomaterials.
Loading efficiency and in vitro drug release behavior
The EE and LE of GA-TiO2 nanocomposites were assessed
and calculated as 74.53% ± 5.43% and 15.11% ± 2.36%, re-
spectively, showing a promising option of TiO2 Ws-loaded
GA to act as an anticancer drug delivery carrier. It could
be seen from Figure 4 that the release of drug molecules
was dependent on the pH of the medium, as well as theFigure 4 In vitro GA release behaviors at pH 7.4 and 6.0
respectively.releasing time. Within 24 h, the drug release ratio was 36%
at pH 7.4, which was slow and sustained, whereas at
pH 6.0, the GA release rate was much faster, with approxi-
mately 87.5%. As mentioned above, the clinical application
of GA has been limited because of its serious side effects.
The result suggests that the side effects to the normal tis-
sues could be greatly reduced due to the prolonged GA re-
tention time in blood circulation, which was down to the
pH-triggered release behavior, namely in the environment
of pH 7.4. In the normal physiological conditions, most
GA is hypothesized to remain in the carrier for a consider-
able time. Once the GA-TiO2 nanocomposites are taken
up by cancer cells via endocytotic process, a faster release
may occur at lower local pH, i.e., surrounding the tumor
site or inside the endosome and lysosome of tumor cells,
causing a tremendous development in cancer treatment
nowadays.
Antitumor activity in vitro
Accumulating data show that GA has a broad spectrum
of antitumor activity against diverse tumor cells, such as
human multiple myeloma U266 cells, human lung car-
cinoma SPC-A1 cells, and human hepatoma SMMC-
7721 cells [21,22]. This potential anticancer activity
in vitro and in vivo is mainly attributed to the downreg-
ulation of telomerase activity and induction of the apop-
totic process [23,24]. However, serious side effects of GA
impede its clinical application. The combined applica-
tion of TiO2 and PDT reduce the concentration of GA,
thus lowering down the side effect.
In the current study, TiO2 Ws could be ingested into
cancer cells, so photocatalytic attack may occur inside
the cancer cells [25]. To explore the possibility of TiO2-
coated GA with UV as a strategy for comprehensive can-
cer treatment, the efficiency of GA-TiO2 composites
under UV irradiation was investigated. It was obvious
that there were no significant differences between the
purple line and blue line in Figure 5, which represent
GA with UV and GA only, respectively, indicating that
UV irradiation itself only showed a slightly enhanced ef-
fect on K562 cells. MTT assay illustrated that UV irradi-
ation could obviously increase the mortality of K562
cells upon incubation with GA-TiO2 nanocomposites
than no UV irradiation, as shown in Figure 5 (green
line). This finding demonstrates that despite the mortal-
ity effects on K562 cells induced by GA, the photocata-
lytic activity of TiO2 Ws could enhance the inhibitation
of growth on cells. The IC50 value (the half maximal in-
hibitory concentration of a substance) was determined
from the dose–response relationship (Figure 5, inset).
The IC50 value of free GA was 1.41 mg/mL for the can-
cer cells; GA with UV and GA-TiO2 composites could
alter the IC50 value to 1.35 and 0.80 mg/mL, respect-
ively. When target cells were treated with GA-TiO2
Figure 5 Cytotoxic effect of GA or GA-TiO2 nanocomposites with/no UV. Cytotoxic effect of GA or GA-TiO2 nanocomposites in the absence
or presence of UV irradiation against K562 cells. Inset: the IC50 of GA and GA-TiO2 nanocomposites in the absence or presence of UV irradiation
for K562 cell.
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reduced to 0.39 mg/mL. Considering that the serious
side effects of GA are related to the high dose of it, the
lower IC50 of GA-TiO2 nanocomposites and GA-TiO2
nanocomposites with UV irradiation improved the effi-
cacy on cancer therapy without high concentration of
GA and minimized its toxic side effects.
GA-TiO2 nanocomposites significantly induced K562 cell
apoptosis
Further study was carried out to observe the morpho-
logical changes of K562 cells. Optical microscopy dem-
onstrated the changes in the morphology of K562 cells
in different experimental conditions. The evaluation of
normal or apoptotic cells depends on morphological
characterization. Normal nuclei (smooth nucleus) and
apoptotic nuclei (condensed or fragmented chromatin)
were easily distinguished. Under fluorescence microscopy,
K562 cells in the control group (treated with 1 μg/mL
GA) were dyed equally with blue fluorescence, indicating
the equivalent distribution of chromatin in the nucleolus,
as shown in Figure 6A. By contrast, when treated with
10 μg/mL TiO2 Ws, GA induced a few K562 cells to
display chromatin condensation and nucleolus pyknosis
(Figure 6B). Figure 6C shows that some cancer cells were
necrotic with the presence of GA-TiO2 nanocomposites,
which was conjugated by 1 μg/mL GA and 10 μg/mL
TiO2 Ws. As shown in Figure 6D, after incubation with
GA-TiO2 nanocomposites under UV irradiation for 24 h,
the cells emitting bright fluorescence increased and dis-
played the typical appearances of apoptosis, includingchromatin condensation, nucleolus pyknosis, nuclear frag-
mentation, and necrosis. Thus, with the assistance of UV
irradiation, cancer cells were killed by the GA-TiO2 nano-
composites in the method of apoptosis instead of necrosis.
Then, the flow cytometry was applied to quantitatively
investigate the apoptosis of K562 cells. After cells were
cultured for 24 h, the total apoptosis rate was 6.6% in
the blank experiments which can be seen in Figure 7
and Additional file 1: Figure S1a. When cultured with
1 μg/mL of GA, the early apoptosis and late apoptosis
rates respectively increased to 17.6% and 5.3% (Figure 7),
and these rates were not significantly different from
those in the blank experiments. Combined with TiO2
Ws and UV irradiation, an apoptosis rate of appro-
ximately 9.0% for K562 was observed. As shown in
Figure 7 and Additional file 1: Figure S1, the early apop-
tosis rate increased to 11.4% and the late apoptosis rate
increased to 18.5%, with a total apoptosis rate increased
to 29.9% after the participation of GA-TiO2 nanocom-
posites in K562 cells. The apoptosis rate of cells further
increased to 59.2% with the application of UV irradiation
in the above system, which shows a tremendous change
compared with that in the control group (P < 0.05).
Depending on all the above observations, a conclusion
that TiO2 Ws could significantly enhance the cytotox-
icity of GA for K562 cells as a drug carrier can be drawn.
In comparing with the negative control of GA, cell mor-
tality increased in the presence of GA-TiO2 nanocompos-
ites. Apart from acting as excellent drug carriers, TiO2 Ws
could also serve as good photosensitizers, which perform
a great potential for PDT to kill cancer cells effectively.
Figure 6 The fluorescence microscopy images of K562 cells. Notes: (A) treated with 1 μg/mL GA; (B) 10 μg/mL TiO2 Ws; (C) and the nanocomposites
with 1 μg/mL GA conjugated with 10 μg/mL TiO2 Ws; (D) with UV irradiation after DAPI dyeing. Scale bar: 20 μm.
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ites, cell viability considerably decreased.
Effect of GA and GA-TiO2 nanocomposites on the cell
cycle by flow cytometry
To investigate the relative mechanism of different systems,
cell cycle study was conducted. According to a previous re-
port, GA can induce G0/G1 arrest and K562 apoptosisFigure 7 Effect of GA, TiO2 Ws, and nanocomposites between
GA- and TiO2-induced apoptosis in K562 cells for 24 h. Notes:
the apoptosis analysis of K562 cells in which K562 cells, K562
incubated with 10 μg/mL TiO2 Ws, K562 incubated with 1 μg/mL
GA, K562 incubated with the nanocomposites with 1 μg/mL GA
conjugated with 10 μg/mL TiO2 Ws, and K562 incubated with GA-TiO2
nanocomposites under UV irradiation.[26]. As shown in Additional file 1: Figure S2A, the ra-
tio of the G0/G1 phase was approximately 39.90% in
the blank experiments of K562 cells, whereas the ratio
of the S phase was approximately 36.52%. These results
indicate that TiO2 Ws had a small effect on the K562
cell cycle, with a ratio of 38.25% in the G0/G1 phase
and 39.84% in the S phase (Additional file 1: Figure
S2B). The ratio of the S phase decreased to 36.26%,
whereas that of the G0/G1 phase increased to 46.88%Figure 8 Effect of GA, TiO2 Ws, and nanocomposites for K562
cells’ cycle under UV irradiation. Notes: effect of GA, TiO2 Ws,
and GA-TiO2 nanocomposites for K562 cells’ cycle; (1) K562 cells;
(2) K562 incubated with 10 μg/mL TiO2 Ws; (3) K562 incubated
with 1 μg/mL GA; (4) K562 incubated with GA-TiO2 nanocomposites
(UV) for 24 h.
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tured with GA for 24 h. When the K562 cells were cul-
tured with GA-TiO2 nanocomposites for 24 h, the G0/G1
phase increased to 52.26% and the S phase decreased to
30.97% (Additional file 1: Figure S2D). The comparison of
the effects of GA, TiO2 Ws, and GA-TiO2 nanocom-
posites on the K562 cell cycle was shown in Figure 8.Figure 9 mRNA expression of apoptosis-associated genes by RQRT-PC
data were normalized to K562 cell blank group. (1) K562 cells were incubat
(3) K562 cells were incubated with GA-TiO2 nanocomposites; (4) K562 cells
data were figured as mean ± SD. #P < 0.05 when compared with the controAn obvious arrest by approximately 5.38% for the G0/
G1 phase was observed compared with the GA-treated
system. Therefore, the GA-TiO2 nanocomposites could
increase the cytotoxicity of GA, leading to the signifi-
cant inhibitation of the growth of K562 cells by per-
turbation of the cycle signaling network (through the
G0/G1 phase).R. K562 cells were treated with different reagents for 24 h. Notes:
ed with same volume of saline; (2) K562 cells were treated with GA;
were incubated with GA-TiO2 nanocomposites with UV irradiation;
l group.
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p27 during induced apoptosis
To explore the preliminary apoptotic mechanisms, the
changes in the expression levels of the apoptosis regulatory
proteins (e.g., caspase-3, CDK2, CDK4, cyclin D1, p21, and
p27) were examined by RT-PCR and Western blot.
In cell proliferation, cyclin D1 displays the crucial
function, which ensures the cell access to S period fromFigure 10 Protein expression of apoptosis-associated genes by Weste
Notes: data were normalized to β-actin expression. (1) K562 cells were incu
(3) K562 cells were incubated with GA-TiO2 nanocomposites; (4) K562 cells
data were figured as mean ± SD. #P < 0.05 when compared with the controG1 period. With the combination of cyclin D1 and
CDK4, leading to the activation of CDK4, the activated
CDK4 promotes the phosphorylation of the downstream
pRb, in which way advances the cell cycle crossing over
checkpoints and leads to abnormal proliferation. CDK2
combines with cyclin E as a complex and phosphorylates
the downstream Rb, which induces the progression of
cell cycle. P21 and P27 play an important role inrn blot. K562 cells were treated with different reagents for 24 h.
bated with same volume of saline; (2) K562 cells were treated with GA;
were incubated with GA-TiO2 nanocomposites with UV irradiation;
l group.
Figure 11 Improvement in antitumor activity by photodynamic TiO2 Ws loading GA. Schematic illustration of the possible mechanism of
distinguished improvement in antitumor activity by photodynamic TiO2 Ws-loading GA.
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the cyclin or cyclin-CDK, resulting in the loss of bio-
logical function of cyclin. PARP is the most important
substrate of caspase-3, which is associated with DNA re-
pair and monitoring of genetic integrity. PARP cannot
develop its normal function when it is cut into two frag-
ments by caspase-3, finally eliciting the apoptosis of
cells. So we can see from Figure 9 that compared with
the control group, transcription of CDK2, CDK4, and
cyclin D1 messenger RNA (mRNA) was downregulated,
and the expression levels of caspase-3, p21, and p27
were upregulated to some extent in GA, GA-TiO2 na-
nocomposites, and GA-TiO2 nanocomposites with UV
irradiation. The same conclusion can be drawn from
Figure 10. These results indicate that photodynamic TiO2
Ws could load GA to induce a marked improvement in
antitumor activity in various apoptotic pathways.
In consequence, on the basis of the above results,
Figure 11 schematically illustrates the possible processes
of photodynamic TiO2 Ws coating GA to induce the
improvement in antitumor activity remarkably. Firstly,
TiO2 Ws can efficiently uptake GA for the unique high-
area properties of them. Secondly, nanocarrier drug
composites have the dual functions: they act as drug
carriers to deliver GA into cancer cells and function as
TiO2 Ws under UV irradiation for PDT at the same
time. With UV irradiation, TiO2 Ws can generate ROS,
which can induce the apoptosis of cells. Therefore, TiO2
Ws can increase the intracellular concentration of GA
dramatically and enhance the suppression of cancer cellproliferation. Meanwhile, the excellent photocatalytic ac-
tivity of TiO2 Ws could enhance the proliferation sup-
pression ability of GA on K562 cells, showing their great
potential in PDT. Thus, TiO2 Ws exhibit an enormous
potential in the application of cancer therapy.
Conclusion
In this study, we explored the potential application of
coupling TiO2 Ws with anticancer drug GA in PDT for the
first time. The results demonstrate that TiO2 Ws have the
feature of uniform diameter distribution and high degree
of crystallinity, and they could be a kind of safe and effica-
cious photosensitizer. Moreover, TiO2 Ws could enhance
the efficacy and lower down the side effects of GA. There-
fore, GA-TiO2 composites in PDT can be a great potential
solution for comprehensive cancer treatment in clinical.
Additional file
Additional file 1: Figure S1. Effect of GA, TiO2 Ws, and nanocomposites
between GA- and TiO2-induced apoptosis in K562 cells for 24 h. a) Control;
b) incubated with 10 μg/ml TiO2; (c) incubated with 1 μg/ml GA; (d)
incubated with 1 μg/ml GA and 10 mg/L TiO2; (e) incubated with
GA-TiO2 nanocomposites for UV irradiation. Figure S2. Effect of GA,
TiO2 Ws, and nanocomposites for K562 cells’ cycle under UV irradiation.
(A) Control; (B) incubated with GA; (C) incubated with TiO2 Ws; (D) incubated
with nanocomposites for 24 h.
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